Compounds > cyclosporine

cyclosporine and Coronary Disease

cyclosporine has been researched along with Coronary Disease in 66 studies

Research

Studies (66)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's39 (59.09)18.2507
2000's26 (39.39)29.6817
2010's1 (1.52)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M1
Ballantyne, CM; Corsini, A; Davidson, MH; Holdaas, H; Jacobson, TA; Leitersdorf, E; März, W; Reckless, JP; Stein, EA1
Harada, H; Rothstein, DM; Sayegh, MH; Sho, M1
Casarini, D; Felipe, CR; Franco, M; Garcia, R; Hanzawa, NM; Hosaka, BH; Lima, VC; Machado, PG; Medina-Pestana, JO; Motegi, S; Park, SI; Tedesco Silva, H1
Abeywickrama, KH; Bernhardt, P; Dorent, R; Eisen, HJ; Hummel, M; Kobashigawa, J; Lind, JM; Mancini, D; Starling, RC; Sørensen, K; Tuzcu, EM; Valantine-von Kaeppler, HA1
Achterhuis, A; Becker, AE; Biezeveld, M; Hack, CE; Kuijpers, TW; Kuipers, I; Lam, J; van der Wal, AC1
Dorent, R; du Montcel, ST; Dubois, M; Gandjbakhch, I; Ghossou, JJ; Isnard, R; Pavie, A; Petitclerc, T; Sénéchal, M1
Angelini, A; Caforio, AL; Feltrin, G; Fortina, AB; Gambino, A; Gerosa, G; Iliceto, S; Piaserico, S; Ramondo, A; Thiene, G; Tona, F; Valente, M1
Briscoe, DM; Denton, MD; Dharnidharka, VR; Magee, C; Melter, M; Sayegh, MH1
Falk, V; Gummert, JF; Kock, M; Lippek, F; Mohr, FW; Richter, H; Richter, MH; Schollmann, HJ; Stilz, HU; Wehner, V1
Argaud, L; Gateau-Roesch, O; Loufouat, J; Ovize, M; Raisky, O; Robert, D1
El-Sayed, O; Ferketich, AK; Leier, CV; Magorien, RD; Orsini, A1
Khaghani, A; Smith, RR; Wray, J; Yacoub, M1
Barnard, JB; Bittar, MN; Hasan, J; Keevil, B; Khasati, N; Martyszczuck, R; Richardson, S; Thekkudan, J; Yonan, N1
Korkmaz, C1
Large, S; Parameshwar, J; Schofield, P1
Libby, P; Nakagawa, T; Rabkin, E; Schoen, FJ; Sukhova, GK; Winters, GL1
Billingham, ME; Brown, BW; Joshi, A; Masek, MA; Weiss, LM1
Arndtz, N; Meiser, B; Reichart, B; Seidel, D; Thiery, J; von Scheidt, W; Wenke, K1
Gamberg, P; Hunt, S; Luikart, H; Miller, J; Valantine, H1
Costard-Jäckle, A; Cremer, J; Haverich, A; Herrmann, G; Simon, R1
Fieguth, HG; Haverich, A; Heublein, B; Jurmann, M; Mügge, A; Oppelt, P; Wahlers, T1
Hammer, M; Laas, J; Laszig, R; Mügge, A; Witte, T; Wollenhaupt, J; Zeidler, H1
Billingham, ME; Fowler, MB; Hunt, SA; Moore, KA; Oyer, PE; Sarris, GE; Schroeder, JS; Stinson, EB; Vagelos, RH; Valantine, HB1
Angoli, L; Campana, C; De Servi, S; Eleuteri, E; Gavazzi, A; Ghio, S; Marioni, R; Montemartini, C; Specchia, G1
Addonizio, LJ; Douglas, JF; Hsu, DT; Kichuk, MR; Michler, RE; Quaegebeur, JM; Rose, EA; Smith, CR1
Gössinger, H; Heinz, G; Kreiner, G; Laczkovics, A; Mösslacher, H; Siostrzonek, P; Stümpflen, A; Teufelsbauer, H1
Grundtner, SE; Ochsner, JL; Price, HL; Smart, FW; Stapleton, DD; Van Meter, C; Ventura, HO1
Demetris, AJ; Griffith, BP; Hattler, BG; Kawai, A; Kormos, RL; Murali, S; Pham, SM1
Casaccia, M; di Summa, M; Marra, S; Mollo, F; Papandrea, C; Passarino, G; Pucci, A1
Hirano, A; Hisatomi, K; Isomura, T; Kohjiro, M; Matsuzoe, S; Satou, T1
Follath, F; Gallino, A; Kaski, JC; Kiowski, W; Tousoulis, D; Turina, M; Vassalli, G1
Cohen, DS; Fisher, RA; Goggins, WC; Grimes, MM; Tawes, JW1
Esper, E; Filer, SR; Glagov, S; Karp, RB; Sand, ME; Scanu, AM; Simonsen, KK1
Ballantyne, CM; el Masri, B; Morrisett, JD; Torre-Amione, G1
Collins, TJ; Karsan, AK; Mehra, MR; Ramee, SR; Smart, FW; Stapleton, DD; Ventura, HO1
Corbetta, G; Ferrara, R; Ferrazzi, P; Fiocchi, R; Gamba, A; Mamprin, F; Senni, M; Troise, G1
Billingham, ME; Hoyt, EG; Pollard, J; Poston, RS; Robbins, RC1
Allan, JS; Arn, JS; Choo, JK; Madsen, JC; Pins, MR; Sachs, DH; Vesga, L1
Arbustini, E; Campana, C; Gavazzi, A; Goggi, C; Grossi, P; Ippoliti, G; Martinelli, L; Pellegrini, C; Regazzi, M; Rinaldi, M; Vigano, M1
Allan, JS; Choo, JK; Erhorn, AE; Madsen, JC; Pins, MR; Sachs, DH; Slisz, JK; Vesga, L; Yamada, K1
Chia, D; Hirata, M; Katznelson, S; Kobashigawa, JA; Ozawa, M; Terasaki, PI; Wang, XM; Zhong, HP1
Amann, K; Dengler, TJ; Hagl, S; Nottmeyer, W; Szabo, G; Vahl, C; Zimmermann, R1
Gregory, CR1
Banner, NL; Busing, K; Crisp, S; Dunn, MJ; Jurcevic, S; Pellegrini, C; Rinaldi, M; Rose, ML; Vigano, M; Yacoub, MH1
Denfield, SW; Frazier, OH; Gajarski, RJ; Kearney, D; Kertesz, NJ; Price, JK; Radovancevic, B; Rosenblatt, HM; Smith, EO; Towbin, JA1
Hisatomi, K1
Barr, ML; Frazier, OH; Mentzer, RM; Radovancevic, B; Renlund, DG; Smart, FW; Taylor, DO; Tolman, DE; VanVeldhuisen, P; Young, JB1
Bölscher, S; Geiger, H; Kachel, HG; Lenz, T; Peschke, B; Scheuermann, EH1
Billingham, M; Hoyt, EG; Morris, RE; Pollard, J; Poston, RS; Robbins, RC; Shorthouse, R1
Blasco, T; Dalmau, R; Delgado, JF; Escribano, P; Gómez-Sánchez, MA; Hernández, J; Morales, JM; Sáenz de la Calzada, C; Sánchez, V; Sotelo, T; Tello, R; Velázquez, T1
Imaizumi, M; Maseki, T; Teranishi, K; Usui, A; Watanabe, T; Yasuura, K2
Patel, SB; Wu, J; Zhu, YH1
Allison, KS; Aretz, HT; Choo, JK; Madsen, JC; Mawulawde, K; Menard, MT; Sachs, DH; Shimizu, A; Slisz, JK; Yamada, K1
Baker, CJ; Barr, ML; McLaughlin, SN; Rose, EA; Schenkel, FA; Starnes, VA; Stouch, BC1
Fiocchi, R; Gamba, A; Iamele, L; Mammana, C; Mamprin, F1
Bernstein, D; Chin, C; Rosenthal, D1
Chinnakotla, S; Fidler, ME; Hammeke, MD; Leone, JP; Tarantolo, S1
Klauss, V; König, A; Meiser, B; Mudra, H; Pfeiffer, M; Regar, E; Reichart, B; Rieber, J; Siebert, U; Spes, C; Theisen, K1
Grabs, R; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M1
Drusin, RE; Edwards, NM; Itescu, S; John, R; Kocher, A; Lietz, K; Mancini, DM; Oz, MC; Rajasinghe, HA; Rose, EA; Smith, CR; Suratwala, S; Suratwalla, S; Weinberg, AD1
Bellón, JM; Buján, J; Gimeno, MJ; Jurado, F; Rodriguez, M1
Berry, GJ; Boeke, K; Hausen, B; Morris, RE1
Al-Mousawi, M; Costandi, JN; Gupta, RK; Johny, KV; Muzairai, I; Nampoory, MR; Ninan, VT; Samhan, M1
Bocksch, W; Fleck, E; Heins, S; Hennersdorf, F; Hetzer, R; Musci, M; Spiegelsberger, S; Wellnhofer, E1

Reviews

6 review(s) available for cyclosporine and Coronary Disease

ArticleYear
Risk for myopathy with statin therapy in high-risk patients.
    Archives of internal medicine, 2003, Mar-10, Volume: 163, Issue:5

    Topics: Calcium Channel Blockers; Coronary Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Immunosuppressive Agents; Muscular Diseases; Risk Factors

2003
Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect.
    Pediatrics, 2003, Volume: 112, Issue:4

    Topics: Aneurysm; C-Reactive Protein; Coronary Disease; Cyclosporine; Cytokines; Drug Resistance; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Salicylates; Serine Endopeptidases

2003
Cyclosporin A and transplant coronary disease after heart transplantation: facts and fiction.
    Transplantation proceedings, 1994, Volume: 26, Issue:5

    Topics: Animals; Aorta; Coronary Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Follow-Up Studies; Heart Transplantation; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Nitroglycerin; Retrospective Studies; Risk Factors; Time Factors

1994
Pathophysiology and treatment of lipid perturbation after cardiac transplantation.
    Current opinion in cardiology, 1997, Volume: 12, Issue:2

    Topics: Acyl Coenzyme A; Animals; Blood Component Removal; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins; Tacrolimus

1997
Immunosuppressive approaches to the prevention of graft vascular disease.
    Transplantation proceedings, 1998, Volume: 30, Issue:3

    Topics: Coronary Disease; Cyclosporine; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Polyenes; Postoperative Complications; Sirolimus; Tacrolimus

1998
Cyclosporine and graft coronary artery disease after heart transplantation.
    Comprehensive therapy, 2000,Summer, Volume: 26, Issue:2

    Topics: Coronary Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Risk Factors

2000

Trials

13 trial(s) available for cyclosporine and Coronary Disease

ArticleYear
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty.
    Transplantation proceedings, 2003, Volume: 35, Issue:3 Suppl

    Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Black People; Cadaver; Coronary Disease; Cyclosporine; Family; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Male; Risk Assessment; Safety; Sirolimus; Tissue Donors; Transplantation, Homologous

2003
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    The New England journal of medicine, 2003, Aug-28, Volume: 349, Issue:9

    Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lipids; Male; Middle Aged; Reoperation; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional

2003
Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy.
    Journal of cardiac failure, 2005, Volume: 11, Issue:2

    Topics: Azathioprine; Coronary Angiography; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Prospective Studies

2005
Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible?
    Transplantation proceedings, 1995, Volume: 27, Issue:3

    Topics: Adult; Coronary Disease; Cyclosporine; Female; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin

1995
Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog.
    Transplantation proceedings, 1994, Volume: 26, Issue:5

    Topics: Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Coronary Disease; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Oligopeptides; Peptides, Cyclic; Postoperative Complications; Prednisolone; Prospective Studies; Somatostatin

1994
Induction immunosuppression with the monoclonal antibody OKT3 after cardiac transplantation.
    The American journal of the medical sciences, 1993, Volume: 306, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Coronary Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Incidence; Kidney Function Tests; Middle Aged; Muromonab-CD3; Postoperative Complications; Survival Analysis; Time Factors; Transplantation, Homologous

1993
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Transplantation proceedings, 1996, Volume: 28, Issue:2

    Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Incidence; Muromonab-CD3; Prednisone; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous

1996
Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1996, Volume: 15, Issue:6

    Topics: Adult; Biopsy; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Transplantation, Homologous

1996
FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1997, Volume: 16, Issue:10

    Topics: Acute Disease; Bacterial Infections; Cardiac Catheterization; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney; Liver; Lymphocyte Subsets; Male; Middle Aged; Nervous System; Prevalence; Prospective Studies; Survival Rate; Tacrolimus; Treatment Outcome

1997
The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998, Volume: 17, Issue:4

    Topics: Adjuvants, Immunologic; Anticholesteremic Agents; Cells, Cultured; Cholesterol; Cholesterol, LDL; Coronary Disease; Cyclosporine; Disease Progression; Drug Synergism; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Incidence; Killer Cells, Natural; Male; Middle Aged; Pravastatin; T-Lymphocytes, Cytotoxic; Transplantation, Homologous

1998
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:4

    Topics: Adult; Biopsy; Cardiomyopathy, Dilated; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Male; Middle Aged; Muromonab-CD3; Prospective Studies; Tacrolimus; Triglycerides

1999
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
    Clinical transplantation, 2000, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; HLA Antigens; Humans; Hyperplasia; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Photopheresis; Pilot Projects; Prednisone; Prospective Studies; Safety; Tunica Intima

2000
Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy.
    The American journal of cardiology, 2000, Jan-15, Volume: 85, Issue:2

    Topics: Adolescent; Adult; Aged; Coronary Disease; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus; Ultrasonography

2000

Other Studies

47 other study(ies) available for cyclosporine and Coronary Disease

ArticleYear
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    International journal of dermatology, 2017, Volume: 56, Issue:4

    Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index

2017
CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathy.
    Transplantation, 2003, Apr-27, Volume: 75, Issue:8

    Topics: Abatacept; Animals; Antibodies, Monoclonal; B7-1 Antigen; Blood Group Incompatibility; CD28 Antigens; CD40 Ligand; Chronic Disease; Coronary Disease; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunoconjugates; Immunosuppressive Agents; Leukocyte Common Antigens; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Sirolimus; Transplantation Tolerance; Transplantation, Homologous

2003
End-stage renal failure and cardiac mortality after heart transplantation.
    Clinical transplantation, 2004, Volume: 18, Issue:1

    Topics: Adult; Case-Control Studies; Coronary Disease; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Male; Retrospective Studies; Risk Factors; Survival Rate; Triglycerides

2004
Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:6

    Topics: Adult; Age of Onset; Anti-Inflammatory Agents; Body Weight; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Prognosis; Risk Factors; Transplantation, Homologous

2004
TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy.
    Transplantation, 2004, Oct-27, Volume: 78, Issue:8

    Topics: Abdomen; Angiogenesis Inhibitors; Animals; Coronary Disease; Cyclohexanes; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Male; O-(Chloroacetylcarbamoyl)fumagillol; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sesquiterpenes; Transplantation, Heterotopic

2004
alpha4beta1-integrin blockade and cyclosporine decreases the prevalence and severity of transplant vasculopathy in a rat transplant model.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:11

    Topics: Animals; Coronary Disease; Cyclosporine; Disease Models, Animal; Heart Transplantation; Hydantoins; Integrin alpha4beta1; Phenylurea Compounds; Prevalence; Rats; Rats, Inbred F344; Rats, Inbred Lew; Severity of Illness Index

2004
Postconditioning inhibits mitochondrial permeability transition.
    Circulation, 2005, Jan-18, Volume: 111, Issue:2

    Topics: Animals; Apoptosis; Calcium; Coronary Disease; Cyclosporine; Extracellular Signal-Regulated MAP Kinases; Ion Channel Gating; Ion Channels; Ion Transport; Male; MAP Kinase Signaling System; Membrane Potentials; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Oxidative Stress; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rabbits; Random Allocation; Time Factors

2005
Ten year survival after paediatric heart transplantation: a single centre experience.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005, Volume: 27, Issue:5

    Topics: Azathioprine; Cardiomyopathies; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Kidney Failure, Chronic; Lymphoproliferative Disorders; Survival Rate; Ultrasonography

2005
Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:5

    Topics: Adult; Coronary Disease; Creatinine; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Monitoring, Physiologic; Myocardium; Postoperative Period; Retrospective Studies; Time Factors; Treatment Outcome

2006
Potential effects of cyclosporin A on coronary vasomotor function in young patients with systemic lupus erythematosus: comment on the article by Hirata et al.
    Arthritis and rheumatism, 2008, Volume: 58, Issue:1

    Topics: Age Factors; Antirheumatic Agents; Coronary Disease; Coronary Vessels; Cyclosporine; Humans; Lupus Erythematosus, Systemic

2008
Long-term complications of cardiac transplantation.
    British heart journal, 1995, Volume: 74, Issue:4

    Topics: Coronary Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Kidney; Neoplasms; Postoperative Complications; Survival Rate; Time Factors

1995
Acute rejection accelerates graft coronary disease in transplanted rabbit hearts.
    Circulation, 1995, Aug-15, Volume: 92, Issue:4

    Topics: Animals; Arteries; Coronary Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Postoperative Complications; Postoperative Period; Rabbits; Time Factors; Vasculitis; Veins

1995
"Quilty" revisited: a 10-year perspective.
    Human pathology, 1995, Volume: 26, Issue:5

    Topics: Adolescent; Adult; Aging; Biopsy; Cardiomyopathies; Coronary Disease; Cyclosporine; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Immunohistochemistry; Lymphoid Tissue; Lymphoproliferative Disorders; Male; Myocardium; Postoperative Care; Postoperative Period; Sex Characteristics; Virus Diseases

1995
Impact of cyclosporine dose on long-term outcome after heart transplantation.
    Transplantation proceedings, 1994, Volume: 26, Issue:5

    Topics: Actuarial Analysis; Antilymphocyte Serum; Azathioprine; Coronary Disease; Cyclosporine; Dose-Response Relationship, Drug; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Muromonab-CD3; Prevalence; Probability; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome

1994
Complicated Cogan's syndrome with aortic insufficiency and coronary stenosis.
    The Journal of rheumatology, 1994, Volume: 21, Issue:3

    Topics: Adult; Antibodies, Bacterial; Aortic Valve Insufficiency; Chlamydia Infections; Chlamydia trachomatis; Cochlear Implants; Combined Modality Therapy; Coronary Disease; Cyclosporine; Deafness; Doxycycline; Female; Humans; Internal Mammary-Coronary Artery Anastomosis; Keratitis; Labyrinth Diseases; Prednisolone; Syndrome

1994
Cardiac transplantation: the Stanford experience in the cyclosporine era.
    The Journal of thoracic and cardiovascular surgery, 1994, Volume: 108, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Child; Child, Preschool; Coronary Disease; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Infant; Infections; Logistic Models; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Survival Analysis

1994
[Coronary vasomotor response to acetylcholine correlates with plasma levels of cyclosporin and triglycerides in patients with heart transplantation].
    Giornale italiano di cardiologia, 1994, Volume: 24, Issue:1

    Topics: Acetylcholine; Adult; Arteries; Coronary Angiography; Coronary Disease; Coronary Vessels; Cyclosporine; Endothelium, Vascular; Heart Transplantation; Humans; Middle Aged; Postoperative Care; Postoperative Complications; Prognosis; Time Factors; Triglycerides; Vasoconstriction

1994
Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
    Circulation, 1993, Volume: 88, Issue:5 Pt 2

    Topics: Azathioprine; Child; Coronary Angiography; Coronary Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Multivariate Analysis; Prednisone; Risk Factors; Time Factors

1993
Relief of diastolic cardiac dysfunction after cyclosporine withdrawal in a cardiac transplant recipient.
    European heart journal, 1993, Volume: 14, Issue:6

    Topics: Coronary Disease; Cyclosporine; Diastole; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Ventricular Function, Left

1993
Pathologic changes in a long-term heterotopic heart transplant survivor.
    Cardiologia (Rome, Italy), 1995, Volume: 40, Issue:6

    Topics: Coronary Disease; Cyclosporine; Fatal Outcome; Graft Occlusion, Vascular; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Proliferating Cell Nuclear Antigen; Transplantation, Heterotopic

1995
Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Transplantation proceedings, 1996, Volume: 28, Issue:3

    Topics: Animals; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Hyperlipidemias; Immunosuppressive Agents; Male; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Heterotopic; Transplantation, Homologous; Triglycerides

1996
Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1996, Volume: 15, Issue:8

    Topics: Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Polyenes; Prevalence; Rats; Rats, Inbred ACI; Rats, Wistar; Sirolimus; Transplantation, Homologous

1996
Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1997, Volume: 16, Issue:4

    Topics: Animals; Cholesterol; Cholesterol, Dietary; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Heart Transplantation; Hypercholesterolemia; Immunosuppressive Agents; Male; Postoperative Complications; Rabbits; Risk Factors

1997
Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.
    American heart journal, 1997, Volume: 133, Issue:6

    Topics: Aorta; Aortic Diseases; Cholesterol; Cohort Studies; Coronary Disease; Coronary Vessels; Cyclosporine; Female; Follow-Up Studies; Forecasting; Heart Transplantation; Humans; Hypercholesterolemia; Hyperplasia; Hypertriglyceridemia; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Transplantation Immunology; Transplantation, Homologous; Triglycerides; Tunica Intima; Ultrasonography, Interventional

1997
The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels.
    Clinical cardiology, 1997, Volume: 20, Issue:9

    Topics: Adolescent; Adult; Aged; Coronary Disease; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate

1997
Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease.
    The Annals of thoracic surgery, 1997, Volume: 64, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Chronic Disease; Coronary Disease; Cyclosporine; Disease Models, Animal; Heart Transplantation; Inflammation; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Inbred ACI; Rats, Inbred Strains; RNA, Messenger; Transplantation, Heterotopic; Up-Regulation

1997
Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy.
    The Annals of thoracic surgery, 1997, Volume: 64, Issue:4

    Topics: Animals; Animals, Inbred Strains; Antibodies, Monoclonal; CD8-Positive T-Lymphocytes; Coronary Disease; Coronary Vessels; Cyclosporine; Heart Transplantation; Lymphocyte Count; Swine; Swine, Miniature; Transplantation, Homologous

1997
Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine.
    Transplantation, 1998, Feb-15, Volume: 65, Issue:3

    Topics: Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Histocompatibility Antigens Class I; Histocompatibility Testing; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Swine; Swine, Miniature; Time Factors; Transplantation, Homologous; Tunica Intima

1998
Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
    Transplantation proceedings, 1998, Volume: 30, Issue:3

    Topics: Animals; Antibodies, Monoclonal; CD2 Antigens; CD4-CD8 Ratio; Coronary Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Postoperative Complications; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Heterotopic; Transplantation, Homologous

1998
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine.
    Transplantation, 1998, May-15, Volume: 65, Issue:9

    Topics: Antibodies; Blotting, Western; Coronary Disease; Cyclosporine; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Postoperative Complications; Postoperative Period; Tacrolimus; Vimentin

1998
Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
    Transplantation, 1998, Jun-15, Volume: 65, Issue:11

    Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Longitudinal Studies; Male; Postoperative Care; Postoperative Complications; Prednisone; Risk Factors; Survival Analysis

1998
Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
    Transplantation proceedings, 1998, Volume: 30, Issue:8

    Topics: Animals; Anticoagulants; Coronary Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Heparin, Low-Molecular-Weight; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Homologous

1998
Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients.
    Clinical nephrology, 1999, Volume: 51, Issue:5

    Topics: Azathioprine; Coronary Disease; Cyclosporine; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Kidney Transplantation; Postoperative Complications; Retrospective Studies

1999
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
    Circulation, 1999, Jul-06, Volume: 100, Issue:1

    Topics: Animals; Antibody Formation; Antibody Specificity; Coronary Disease; Cyclosporine; Drug Evaluation, Preclinical; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Heart Transplantation; Histocompatibility; Histocompatibility Antigens; Immunity, Cellular; Immunoglobulin G; Immunosuppressive Agents; Isoantibodies; Male; Nitric Oxide; Rats; Rats, Inbred ACI; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred WF; Reproducibility of Results; Sirolimus; Transplantation, Homologous

1999
Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
    Transplantation proceedings, 1999, Volume: 31, Issue:6

    Topics: Azathioprine; Cardiomyopathy, Dilated; Coronary Disease; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies

1999
Effect of Tranilast on chronic graft vascular disease and tracheal proliferation in a rat allograft model.
    Transplantation proceedings, 1999, Volume: 31, Issue:7

    Topics: Animals; Cell Division; Chronic Disease; Coronary Disease; Cyclosporine; Graft vs Host Disease; Heart Transplantation; Male; ortho-Aminobenzoates; Platelet Aggregation Inhibitors; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Trachea; Transplantation, Heterotopic; Transplantation, Homologous

1999
Dose- and time-related acceleration of chronic graft vascular disease caused by cyclosporine in a rat cardiac isograft model.
    Transplantation proceedings, 1999, Volume: 31, Issue:7

    Topics: Administration, Oral; Animals; Chronic Disease; Coronary Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Transplantation; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred ACI; Time Factors; Transplantation, Isogeneic

1999
Cyclosporin-induced dyslipoproteinemia is associated with selective activation of SREBP-2.
    The American journal of physiology, 1999, Volume: 277, Issue:6

    Topics: Acetyl-CoA Carboxylase; Animals; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Cholesterol, VLDL; Coronary Disease; Cyclosporine; Cytochrome P-450 Enzyme System; DNA-Binding Proteins; Farnesyl-Diphosphate Farnesyltransferase; Fatty Acid Synthases; Fatty Acids; Female; Gene Expression Regulation, Enzymologic; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Immunosuppressive Agents; Immunotherapy; Leucine Zippers; Lipase; Liver; Mice; Receptors, LDL; RNA, Messenger; Stearoyl-CoA Desaturase; Steroid Hydroxylases; Sterol Regulatory Element Binding Protein 2; Sterols; Transcription Factors; Transcription, Genetic; Triglycerides

1999
Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
    The Journal of thoracic and cardiovascular surgery, 2000, Volume: 119, Issue:4 Pt 1

    Topics: Animals; Coronary Disease; Cyclosporine; Cytotoxicity, Immunologic; Graft Enhancement, Immunologic; Graft Rejection; Heart Transplantation; Immune Tolerance; Immunosuppressive Agents; Kidney Transplantation; Leukocyte Transfusion; Major Histocompatibility Complex; Myocardium; Swine; Swine, Miniature; Thymectomy; Transplantation Chimera

2000
Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.
    Pediatric transplantation, 2000, Volume: 4, Issue:3

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Coronary Disease; Cyclosporine; Female; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Infant; Lipoproteins; Male; Prednisone; Prevalence; Regression Analysis; Risk Factors; Statistics, Nonparametric; Tacrolimus

2000
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.
    Transplantation, 2000, Aug-15, Volume: 70, Issue:3

    Topics: Adult; Clopidogrel; Coronary Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Ticlopidine

2000
New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2000, Volume: 19, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Losartan; Male; Premedication; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterotopic

2000
Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era.
    Journal of the American College of Cardiology, 2001, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Cause of Death; Child; Coronary Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Risk Factors; Survival Analysis

2001
Function of inflammatory cells and neoral cyclosporin-A in heart transplant-associated coronary vasculopathy.
    Histology and histopathology, 2001, Volume: 16, Issue:1

    Topics: Actins; Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Emulsions; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Male; Neovascularization, Pathologic; Rats; Rats, Inbred F344; Rats, Inbred Lew

2001
Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts.
    Transplantation, 2001, Aug-15, Volume: 72, Issue:3

    Topics: Animals; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Myocardial Ischemia; Myocardium; Postoperative Care; Rats; Serine Proteinase Inhibitors; Serpins; Time Factors; Transplantation, Heterologous; Transplantation, Homologous; Viral Proteins

2001
High incidence of post-transplant diabetes mellitus in Kuwait.
    Diabetes research and clinical practice, 2002, Volume: 55, Issue:2

    Topics: Adult; Azathioprine; Cause of Death; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Kuwait; Male; Middle Aged; Prednisone; Survival Rate

2002
Aspects of cyclosporine A toxicity in the development of coronary artery disease in transplant recipients.
    Transplantation proceedings, 2002, Volume: 34, Issue:4

    Topics: Adult; Azathioprine; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Models, Cardiovascular; Postoperative Complications; Regression Analysis; Retrospective Studies

2002